Literature DB >> 10072042

Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children.

D C Chugani1, O Muzik, M Behen, R Rothermel, J J Janisse, J Lee, H T Chugani.   

Abstract

Serotonin content, serotonin uptake sites, and serotonin receptor binding measured in animal studies are all higher in the developing brain, compared with adult values, and decline before puberty. Furthermore, a disruption of synaptic connectivity in sensory cortical regions can result from experimental increase or decrease of brain serotonin before puberty. The purpose of the present study was to determine whether brain serotonin synthesis capacity is higher in children than in adults and whether there are differences in serotonin synthesis capacity between autistic and nonautistic children. Serotonin synthesis capacity was measured in autistic and nonautistic children at different ages, using alpha[11C]methyl-L-tryptophan and positron emission tomography. Global brain values for serotonin synthesis capacity (K complex) were obtained for autistic children (n = 30), their nonautistic siblings (n = 8), and epileptic children without autism (n = 16). K-complex values were plotted according to age and fitted to linear and five-parameter functions, to determine developmental changes and differences in serotonin synthesis between groups. For nonautistic children, serotonin synthesis capacity was more than 200% of adult values until the age of 5 years and then declined toward adult values. Serotonin synthesis capacity values declined at an earlier age in girls than in boys. In autistic children, serotonin synthesis capacity increased gradually between the ages of 2 years and 15 years to values 1.5 times adult normal values and showed no sex difference. Significant differences were detected between the autistic and epileptic groups and between the autistic and sibling groups for the change with age in the serotonin synthesis capacity. These data suggest that humans undergo a period of high brain serotonin synthesis capacity during childhood, and that this developmental process is disrupted in autistic children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072042     DOI: 10.1002/1531-8249(199903)45:3<287::aid-ana3>3.0.co;2-9

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  167 in total

Review 1.  The pathophysiology and treatment of autism.

Authors:  D J Posey; C J McDougle
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 2.  Neuroimaging in child and adolescent psychiatric disorders.

Authors:  P J Santosh
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

Review 3.  The neurobiology of autism: new pieces of the puzzle.

Authors:  Maria T Acosta; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

Review 4.  Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.

Authors:  Ayesha C Sujan; A Sara Öberg; Patrick D Quinn; Brian M D'Onofrio
Journal:  J Child Psychol Psychiatry       Date:  2018-12-05       Impact factor: 8.982

5.  Secretin and autism: a two-part clinical investigation.

Authors:  M G Chez; C P Buchanan; B T Bagan; M S Hammer; K S McCarthy; I Ovrutskaya; C V Nowinski; Z S Cohen
Journal:  J Autism Dev Disord       Date:  2000-04

Review 6.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

7.  Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

Authors:  C J McDougle; L E Kresch; D J Posey
Journal:  J Autism Dev Disord       Date:  2000-10

8.  Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.

Authors:  Nicholas J Heyer; Diana Echeverria; James S Woods
Journal:  Autism Res       Date:  2012-02-01       Impact factor: 5.216

9.  Protocadherin α (PCDHA) as a novel susceptibility gene for autism.

Authors:  Ayyappan Anitha; Ismail Thanseem; Kazuhiko Nakamura; Kazuo Yamada; Yoshimi Iwayama; Tomoko Toyota; Yasuhide Iwata; Katsuaki Suzuki; Toshiro Sugiyama; Masatsugu Tsujii; Takeo Yoshikawa; Norio Mori
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

10.  The minicolumnopathy of autism: A link between migraine and gastrointestinal symptoms.

Authors:  Manuel F Casanova
Journal:  Med Hypotheses       Date:  2007-06-14       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.